The following discussion of the Company's operations and financial condition
should be read in conjunction with the Financial Statements and notes thereto
included elsewhere in this Quarterly Report.

In the following discussions, most percentages and dollar amounts have been rounded to aid presentation. Accordingly, all amounts are approximations.

Forward-Looking Information

This report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.



Forward-looking statements include statements with respect to the Company's
beliefs, plans, objectives, goals, expectations, anticipations, assumptions,
estimates, intentions, and future performance, and involve known and unknown
risks, uncertainties and other factors, which may be beyond the Company's
control, and which may cause the Company's actual results, performance or
achievements to be materially different from future results, performance or
achievements expressed or implied by such forward-looking statements.

All statements other than statements of historical fact are statements that
could be forward-looking statements. The reader can identify these
forward-looking statements through the Company's use of words such as "may,"
"will," "can," "anticipate," "assume," "should," "indicate," "would," "believe,"
"contemplate," "expect," "seek," "estimate," "continue," "plan," "project,"
"predict," "could," "intend," "target," "potential," and other similar words and
expressions of the future. These forward-looking statements may not be realized
due to a variety of factors, including, without limitation:

• the ongoing effects of the coronavirus (COVID-19) pandemic-related

business disruption and economic uncertainty on both the Company's

projected customer demand and supply chain, as well as its operations and

financial performance;

• the Company's ability to generate sufficient revenue to achieve and

maintain profitability;

• the Company's ability to obtain new customers and retain key existing

customers, including the Company's ability to maintain purchase volumes of


        the Company's products by its key customers;


    •   the Company's ability to obtain new licensees and distribution

relationships and maintain relationships with its existing licensees and

distributors;

• the Company's ability to resist price increases from its suppliers or pass

through such increases to its customers;

• changes in consumer spending for retail products, such as the Company's

products, and in consumer practices, including sales over the Internet;




    •   the Company's ability to maintain effective internal controls or
        compliance by its personnel with such internal controls;

• the Company's ability to successfully manage its operating cash flows to

fund its operations;

• the Company's ability to anticipate market trends, enhance existing


        products or achieve market acceptance of new products;


    •   the Company's ability to accurately forecast consumer demand and
        adequately manage inventory;


    •   the Company's dependence on a limited number of suppliers for its
        components and raw materials;

• the Company's dependence on third party manufacturers to manufacture and

deliver its products;

• increases in shipping costs for the Company's products or other service

issues with the Company's third-party shippers;

• the Company's dependence on a third party logistics provider for the

storage and distribution of its products in the United States;

• the ability of third party sales representatives to adequately promote,

market and sell the Company's products;

• the Company's ability to maintain, protect and enhance its intellectual


        property;


  • the effects of competition;

• the Company's ability to distribute its products in a timely fashion,


        including as a result of labor disputes and public health threats and
        social unrest;

• evolving cybersecurity threats to the Company's information technology


        systems or those of its customers or suppliers;


                                       14

--------------------------------------------------------------------------------

• changes in foreign laws and regulations and changes in the political and


        economic conditions in the foreign countries in which the Company
        operates;


  • changes in accounting policies, rules and practices;


  • changes in tax rules and regulations or interpretations;

• changes in U.S. and foreign trade regulations and tariffs, including


        potential increases of tariffs on goods imported into the U.S., and
        uncertainty regarding the same;


  • limited access to financing or increased cost of financing;

• the effects of currency fluctuations between the U.S. dollar and Chinese

renminbi relative to the dollar and increases in costs of production in

China; and

• the other factors listed under "Risk Factors" in the Company's Form 10-K,

as amended, for the fiscal year ended March 31, 2021 and other filings

with the SEC.




Furthermore, the situation surrounding the COVID-19 pandemic remains fluid and
the potential for a material impact on the Company's results of operations and
financial condition increases the longer the COVID-19 pandemic affects activity
levels in the United States and globally. For this reason, the Company cannot
reasonably estimate with any degree of certainty the future impact COVID-19 may
have on its business, results of operations or financial position. The extent of
any impact will depend on future developments, including the duration of the
outbreak, duration of the measures taken to control the spread, the
effectiveness of actions taken to contain and treat the disease, and demand for
the Company's products.

All forward-looking statements are expressly qualified in their entirety by this
cautionary notice. The reader is cautioned not to place undue reliance on any
forward-looking statements, which speak only as of the date of this report or
the date of the document incorporated by reference into this report. The Company
has no obligation, and expressly disclaims any obligation, to update, revise or
correct any of the forward-looking statements, whether as a result of new
information, future events or otherwise. The Company has expressed its
expectations, beliefs and projections in good faith and it believes it has a
reasonable basis for them. However, the Company cannot assure the reader that
its expectations, beliefs or projections will result or be achieved or
accomplished.

Results of Operations



The following table summarizes certain financial information for the three and
nine month periods ended December 31, 2021 (fiscal 2022) and December 31, 2020
(fiscal 2021) (in thousands):



                                         Three Months Ended December 31,          Nine Months Ended December 31,
                                          2021                  2020                2021                  2020
Net product sales                      $     2,509         $         2,273     $         6,290       $         5,718
Licensing revenue                               65                      60                 195                   180
Net revenues                                 2,574                   2,333               6,485                 5,898
Cost of sales                                1,826                   1,754               4,786                 4,519
Selling, general and administrative
expenses                                     1,469                   1,560               4,196                 4,601
Operating loss                                (721 )                  (981 )            (2,497 )              (3,222 )
Loss on settlement of litigation              (450 )                     -                (450 )                   -
Interest income, net                             7                      18                  40                   128
Income from governmental assistance
programs                                         -                      28                 207                    83
Loss before income taxes                    (1,164 )                  (935 )            (2,700 )              (3,011 )
Provision for income taxes                       -                      10                  11                    15
Net loss                               $    (1,164 )       $          (945 )   $        (2,711 )     $        (3,026 )




Net product sales - Net product sales for the three month period ended December
31, 2021 were $2.5 million as compared to $2.3 million for the three month
period ended December 31, 2020, an increase of $0.2 million, or 10.4%. The
Company's sales during the three month periods ended December 31, 2021 and
December 31, 2020 were highly concentrated among the Company's three largest
customers - Wal-Mart, Amazon and Fred Meyer - comprising in the aggregate
approximately 94% and 90%, respectively, of the Company's total net product
sales.



Net product sales for the nine month period ended December 31, 2021 were $6.3
million as compared to $5.7 million for the nine month period ended December 31,
2020, an increase of $0.6 million, or 10.0%. The Company's sales during such
periods were highly concentrated among the Company's three largest customers -
Wal-Mart, Amazon and Fred Meyer - comprising in the aggregate approximately 91%
and 83%, respectively, of the Company's total net product sales.

                                       15

--------------------------------------------------------------------------------


Net product sales may be periodically impacted by adjustments made to the
Company's sales allowance and marketing support accrual to record unanticipated
customer deductions from accounts receivable or to reduce the accrual by any
amounts which were accrued in the past but not taken by customers through
deductions from accounts receivable within a certain time period. In the
aggregate, these adjustments had the effect of increasing net product sales and
operating income by approximately $6,000 and $3,000 for the three month periods
ended December 31, 2021 and December 31, 2020, respectively, and approximately
$12,000 and $46,000 for the nine month periods ended December 31, 2021 and
December 31, 2020, respectively. Net product sales are comprised primarily of
the sales of houseware and audio products which bear the Emerson® brand name.
The major elements which contributed to the overall increase in net product
sales were as follows:

i) Houseware products: Net sales decreased $0.3 million, or 54.2%, to $0.3

million for the three month period ended December 31, 2021 as compared to

$0.6 million for the three month period ended December 31, 2020, driven by

a decrease in year-over-year sales of microwave ovens. For the nine month

period ended December 31, 2021, houseware net product sales were $1.5

million, a decrease of $0.6 million, or 29.6%, from $2.1 million for the


        nine month period ended December 31, 2020, driven by a decrease in
        year-over-year sales of microwave ovens.


    ii) Audio products: Net sales increased $0.5 million, or 32.8%, to $2.2

million for the three month period ended December 31, 2021 as compared to

$1.7 million for the three month period ended December 31, 2020, resulting

from increased net sales of clock radios. For the nine month period ended

December 31, 2021, audio product net sales were $4.8 million, an increase


        of $1.2 million or 33.9%, from $3.6 million for the nine month period
        ended December 31, 2020 resulting from increased net sales of clock
        radios.


Business operations - The Company expects to continue to expand its existing
distribution channels and to develop and promote new products with retailers in
the U.S. The Company is also continuing to invest in products and marketing
activities to expand its sales through internet and ecommerce channels. These
efforts require investments in appropriate human resources, media marketing and
development of products in various categories in addition to the traditional
home appliances and audio products on which the Company has historically
focused. The Company also is continuing its efforts to identify strategic
courses of action related to its licensing activities, including seeking new
licensing relationships. The Company has engaged LMCA as an agent to assist in
identifying and procuring potential licensees.

Emerson's success is dependent on its ability to anticipate and respond to
changing consumer demands and trends in a timely manner, as well as expanding
into new markets and sourcing new products that are profitable to the Company.
Geo-political factors may also affect the Company's operations and demand for
the Company's products, which are subject to customs requirements and to tariffs
and quotas set by governments through mutual agreements and bilateral actions.
The Company expects that current and proposed U.S. tariffs on categories of
products that the Company imports from China, and China's retaliatory tariffs on
certain goods imported from the United States, as well as modifications to
international trade policy, will continue to affect its product costs going
forward. If no mitigation steps are taken, or the mitigation is unsuccessful,
the combination of tariffs will result in significantly increased annualized
costs to the Company as all of the Company's products are currently manufactured
by suppliers in China. Although the Company is monitoring the trade and
political environment and working to mitigate the possible effect of tariffs
with its suppliers as well as its customers through pricing and sourcing
strategies, the Company cannot be certain how its customers and competitors will
react to the actions taken. In addition, heightened tensions between the United
States and China over Hong Kong and any resulting retaliatory policies may
affect our operations in Hong Kong. At this time the Company is unable to
quantify possible effects on its costs arising from the new tariffs, which are
expected to increase the Company's inventory costs and associated costs of sales
as tariffs are incurred, and some costs may be passed through to the Company's
customers as product price increases in the future. However, if the Company is
unable to successfully pass through the additional costs or otherwise mitigate
the effects of these tariffs, or if the higher prices reduce demand for the
Company's products, it will have a negative effect on the Company's product
sales and gross margins.

Starting in the fourth quarter of fiscal 2020, the global COVID-19 pandemic has
presented significant challenges and impacted the Company's business and
operating results, and the operations and production capabilities of the
Company's suppliers in China and the distribution capabilities of the Company's
third party logistics provider, including as a result of quarantine or closure.
The pandemic has directly and indirectly disrupted certain sales and supply
chain activities and affected the Company's ability to address those challenges.
Although the Company has since experienced increased demand in certain of its
product categories and favorable impacts on its online channels as a result of
the COVID-19 pandemic, the Company expects that the pandemic will continue to
impact its business and operations over the coming quarters, including with
respect to the magnitude and timing of orders by retailers, resellers,
distributors and consumers. Additionally, surges in demand and shifts in
shopping patterns related to the COVID-19 pandemic have strained the global
freight network and availability of shipping containers, which has been further
exacerbated by COVID-19 outbreaks and protocols at many port locations,
resulting in carrier-imposed capacity restrictions, carrier delays and longer
lead times, including shipment receiving and unloading backlogs at many U.S.
ports. As a result, the Company's shipping costs have recently increased by
several multiples compared to fiscal 2021 averages. Global component shortages,
in particular semiconductor chips, arising from these changes in consumer demand
and reduced manufacturing capacity related to the COVID-19 pandemic have also
caused and are likely to continue to result in significant price fluctuations
and long lead times in the supply of these components. Although the Company is
seeking alternate suppliers for these components, developing alternate sources
of supply will be time consuming, difficult and costly, and may require the
re-tooling of products to accommodate components from different suppliers. In
addition to increasing cost trends, the Company's suppliers are not equipped to
hold meaningful amounts of inventory and if shipping container capacity remains
limited or unavailable, they could pause manufacturing, which could ultimately
impact the Company's

                                       16

--------------------------------------------------------------------------------


ability to fulfill customer orders on a timely basis. These impacts on the
Company's supply chain have and may continue to impact the Company's ability to
meet product demand, which could result in additional costs, customer
dissatisfaction in the event of inventory shortages or may otherwise adversely
impact the Company's business and results of operations.

In light of the adverse effects of the COVID-19 pandemic on macroeconomic
conditions domestically and internationally, along with the uncertainty
associated with a potential recovery, the Company has implemented certain
cost-reduction actions intended to reduce expenditures in light of the effects
of the COVID-19 pandemic to the business. However, the environment remains
highly uncertain and demand for the Company's products remains difficult to
assess due to many factors including the pace of economic recovery around the
world, the status of various government stimulus programs, competitive intensity
and retailer actions to continue carefully managing inventory. As a result, the
Company is unable at this time to predict the full impact of the COVID-19
pandemic on its operations and financial results, and, depending on the
magnitude and duration of the pandemic, including the further spread and
severity of COVID-19 cases in areas in which the Company operates and the
availability and distribution of effective vaccines, such impact may be
material. Accordingly, current results and financial condition discussed herein
may not be indicative of future operating results and trends

For more information on risks associated with the Company's operations,
including tariffs, please see the risk factors within Part I, Item 1A, "Risk
Factors" in the Company's Annual Report on Form 10-K, as amended, for the year
ended March 31, 2021.

Licensing revenue - Licensing revenue for the three month period ended December
31, 2021 was $65,000 as compared to $60,000 for the three month period ended
December 31, 2020, an increase of $5,000, or 8.3%. The year-over-year increase
can be attributed to the escalation in the annual minimum royalty earned by the
Company from its licensee.

Licensing revenue for the nine month period ended December 31, 2021 was $195,000
as compared to $180,000 for the nine month period ended December 31, 2020, an
increase of $15,000, or 8.3%. The year-over-year increase can be attributed to
the escalation in the annual minimum royalty earned by the Company from its
licensee.

Net revenues - As a result of the foregoing factors, the Company's net revenues
were $2.6 million for the three month period ended December 31, 2021 as compared
to $2.3 million for the three month period ended December 31, 2020, an increase
of $0.3 million, or 10.3%, and $6.5 million for the nine month period ended
December 31, 2021 as compared to $5.9 million for the nine month period ended
December 31, 2020, an increase of $0.6 million, or 10.0%

Cost of sales - In absolute terms, cost of sales increased $0.1 million, or
4.1%, to $1.8 million for the three month period ended December 31, 2021 as
compared to $1.7 million for the three month period ended December 31, 2020. The
increase in absolute terms for the three month period ended December 31, 2021 as
compared to the three month period ended December 31, 2020 was primarily related
to an increase in net product sales partially offset by lower year-over-year
gross cost of sales as a percentage of gross sales.

In absolute terms, cost of sales increased $0.3 million, or 5.9%, to $4.8
million for the nine month period ended December 31, 2021 as compared to $4.5
million for the nine month period ended December 31, 2020. The increase in
absolute terms for the nine month period ended December 31, 2021 as compared to
the nine month period ended December 31, 2020 was primarily related to an
increase in net product sales partially offset by lower year-over-year gross
cost of sales as a percentage of gross sales.

The Company purchases the products it sells from a limited number of factory
suppliers. For the three month periods ended December 31, 2021 and December 31,
2020, the Company purchased 100% and 95%, respectively, from its two largest
suppliers. For the nine month periods ended December 31, 2021 and December 31,
2020, the Company purchased 100% and 98%, respectively, from its two largest
suppliers.

Selling, general and administrative expenses ("S,G&A") - S,G&A, in absolute
terms, was $1.5 million for the three month period ended December 31, 2021 as
compared to $1.6 million for three month period ended December 31, 2020, a
decrease of $0.1 million or 5.8%. S,G&A, as a percentage of net revenues, was
57.1% for the three month period ended December 31, 2021 as compared to 66.9%
for the three month period ended December 31, 2020. The decrease in S,G&A was
primarily attributed to a decrease in compensation costs of approximately
$113,000. Compensation costs for the three month period ended December 31, 2021
were $531,000 as compared to $644,000 for the three month period ended December
31, 2020.

S,G&A, in absolute terms, was $4.2 million for the nine month period ended
December 31, 2021 as compared to $4.6 million for the nine month period ended
December 31, 2020, a decrease of $0.4 million, or 8.8%. S,G&A, as a percentage
of net revenues, was 64.7% for the nine month period ended December 31, 2021 as
compared to 78.0% for the nine month period ended December 31, 2020. The
decrease in S,G&A was primarily attributed to a decrease in legal fees of
approximately $245,000 and a decrease in compensation costs of approximately
$126,000. Legal fees for the nine month period ended December 31, 2021 were
approximately $1,100,000 as compared to approximately $1,345,000 for the nine
month period ended December 31, 2020. The majority of the decrease in legal fees
concerned the protection of the Emerson® trademark. Compensation costs for the
nine month period ended December 31, 2021 were approximately $1,770,000 as
compared to approximately $1,896,000 for the nine month period ended December
31, 2020. The majority of the decrease in compensation costs were due to
headcount reductions.


                                       17

--------------------------------------------------------------------------------




Loss on settlement of litigation - During the three month period ended December
31, 2021, a settlement agreement between the Company and one of its former
directors was entered into regarding an indemnification claim. The amount of the
settlement was $450,000. See "Note 11 - Subsequent Event".

Interest income, net - Interest income, net, was $7,000 for the three month
period ended December 31, 2021 as compared to $18,000 for the three month period
ended December 31, 2020, a decrease of $11,000. The decrease was primarily due
to lower average interest rates earned on the Company's short term investments.

Interest income, net, was $40,000 for the nine month period ended December 31,
2021 as compared to $128,000 for the nine month period ended December 31, 2020,
a decrease of $88,000. The decrease was primarily due to lower average interest
rates earned on the Company's short term investments.

Income from governmental assistance programs - For the three and nine month
periods ended December 31, 2021, the Company recorded income of approximately
nil and $207,000, respectively, related to its PPP loan forgiveness. For the
three and nine month periods ended December 31, 2020, the Company recorded
income of approximately $28,000 and $83,000, respectively, related to assistance
received from the Hong Kong government under the ESS program. See "Note 10
- Paycheck Protection Program and Employment Support Scheme".

Provision (benefit) for income taxes - For the three month period ended December
31, 2021, the Company recorded income tax expense of nil as compared to income
tax expense of $9,900 for the three month period ended December 31, 2020. See
"Note 5 - Income Taxes".

For the nine month period ended December 31, 2021, the Company recorded income
tax expense of $11,000 as compared to income tax expense of $15,200 for the nine
month period ended December 31, 2020.

Although the Company generated net losses during fiscal 2022 and fiscal 2021, it
was unable to realize an income tax benefit due to valuation allowances recorded
against its deferred tax assets.

Net (loss) - As a result of the foregoing factors, the Company realized a net
loss of $1,164,000 for the three month period ended December 31, 2021 as
compared to a net loss of $945,000 for the three month period ended December 31,
2020.

For the nine month period ended December 31, 2021, the Company realized a net
loss of $2,711,000 as compared to a net loss of $3,026,000 for the nine month
period ended December 31, 2020.

Liquidity and Capital Resources



As of December 31, 2021, the Company had cash and cash equivalents of
approximately $24.7 million as compared to approximately $5.2 million at March
31, 2021. Working capital decreased to $29.0 million at December 31, 2021 as
compared to $32.1 million at March 31, 2021. The increase in cash and cash
equivalents of approximately $19.5 million was due to the decrease in short term
investments of $25.0 million, an increase of $0.4 million in accounts payable
and other current liabilities and the increase in long term lease liabilities of
$0.2 million offset by the net loss generated during the period of $2.7 million,
an increase in accounts receivable of $1.9 million, an increase in inventory of
$0.6 million, an increase in right of use assets of $0.2 million, a decrease in
federal taxes payable of $0.2 million, a decrease in PPP loan payable of $0.2
million, a decrease in deferred revenue of $0.2 million and an increase in
prepaid expenses and other current assets of $0.1 million.

Cash Flows



Net cash used by operating activities was approximately $5.5 million for the
nine month period ended December 31, 2021, resulting from a $2.7 million net
loss generated during the period, an increase in accounts receivable of $2.1
million, an increase in inventory of $0.6 million, an increase in right of use
assets of $0.4 million, a decrease in federal taxes payable of $0.2 million, the
impact of the PPP loan forgiveness of $0.2 million partially offset by an
increase in accounts payable and other current liabilities of $0.4 million, an
increase in long-term lease liabilities of $0.2 million and a decrease in
prepaid purchases of $0.1 million.

Net cash provided by investing activities was approximately $25.0 million for
the nine month period ended December 31, 2021 due to a decrease in short term
deposits.

Net cash used by financing activities was nil for the nine month period ended December 31, 2021.



                                       18

--------------------------------------------------------------------------------

Sources and Uses of Funds



The Company's principal existing sources of cash are generated from operations
and its existing short-term investments. The Company believes that its existing
cash balance and sources of cash will be sufficient to support existing
operations over the next 12 months.

Paycheck Protection Program Loan



In April and May of 2020, the Company applied for and received aggregate loan
proceeds of approximately $0.2 million under the PPP. The PPP loan accrued
interest at 1% and matures two years from the date of issuance, with a deferral
of payments for the first six months. The Company used all of the PPP loan
proceeds for qualifying expenses in accordance with terms of the CARES Act and
applied for forgiveness of the loan to the extent applicable. On July 5, 2021,
the Company's PPP loan was completely forgiven by the Small Business
Administration. See Note 10 of the Notes to the Interim Consolidated Financial
Statements.

Off-Balance Sheet Arrangements

As of December 31, 2021, the Company did not have any off-balance sheet arrangements as defined under the rules of the SEC.

Recently Adopted Accounting Pronouncements

Accounting Standards Update 2019-12 "Income Taxes (Topic 740) - Simplifying the Accounting for Income Taxes" (Issued December 2019)



In December 2019, the FASB issued ASU 2019-12, "Income Taxes (Topic 740) -
Simplifying the Accounting for Income Taxes," which is intended to simplify
various aspects related to accounting for income taxes. ASU 2019-12 removes
certain exceptions to the general principles in Topic 740 and also clarifies and
amends existing guidance to improve consistent application. ASU 2019-12 is
effective for fiscal years beginning after December 15, 2020. This standard took
effect in the first quarter (June 2021) of the Company's fiscal year ending
March 31, 2022. The adoption of ASU 2019-12 had no material impact on the
Company's consolidated financial statements and related disclosures.



Recently Issued Accounting Pronouncements



The following ASUs were issued by the FASB which relate to or could relate to
the Company as concerns the Company's normal ongoing operations or the industry
in which the Company operates.

Accounting Standards Update 2016-13 "Financial Instruments - Credit Losses" (Issued June 2016)



In June 2016, the FASB issued ASU 2016-13 "Financial Instruments - Credit
Losses" to introduce new guidance for the accounting for credit losses on
instruments within its scope. ASU 2016-13 requires among other things, the
measurement of all expected credit losses for financial assets held at the
reporting date based on historical experience, current conditions, and
reasonable supportable forecasts. Many of the loss estimation techniques applied
today will still be permitted, although the inputs to those techniques will
change to reflect the full amount of expected credit losses. In addition, ASU
2016-13 amends the accounting for credit losses on available-for-sale debt
securities and purchased financial assets with credit deterioration. ASU 2016-13
is effective for fiscal years and interim periods beginning after December 15,
2022. Early adoption is permitted. The Company does not expect these amendments
to have a material impact on its financial statements.

© Edgar Online, source Glimpses